GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:19030351 | Liver | Cirrhotic | negative regulation of response to wounding | 34/4634 | 94/18723 | 8.84e-03 | 4.08e-02 | 34 |
GO:00071624 | Liver | Cirrhotic | negative regulation of cell adhesion | 93/4634 | 303/18723 | 1.06e-02 | 4.66e-02 | 93 |
GO:002241112 | Liver | HCC | cellular component disassembly | 282/7958 | 443/18723 | 1.02e-19 | 1.38e-17 | 282 |
GO:004586222 | Liver | HCC | positive regulation of proteolysis | 232/7958 | 372/18723 | 5.66e-15 | 3.98e-13 | 232 |
GO:004440322 | Liver | HCC | biological process involved in symbiotic interaction | 183/7958 | 290/18723 | 9.13e-13 | 4.59e-11 | 183 |
GO:001056322 | Liver | HCC | negative regulation of phosphorus metabolic process | 259/7958 | 442/18723 | 4.29e-12 | 1.92e-10 | 259 |
GO:004593622 | Liver | HCC | negative regulation of phosphate metabolic process | 258/7958 | 441/18723 | 6.00e-12 | 2.60e-10 | 258 |
GO:004232622 | Liver | HCC | negative regulation of phosphorylation | 227/7958 | 385/18723 | 3.98e-11 | 1.52e-09 | 227 |
GO:005134822 | Liver | HCC | negative regulation of transferase activity | 166/7958 | 268/18723 | 8.97e-11 | 3.18e-09 | 166 |
GO:003367322 | Liver | HCC | negative regulation of kinase activity | 144/7958 | 237/18723 | 9.76e-09 | 2.45e-07 | 144 |
GO:005160412 | Liver | HCC | protein maturation | 171/7958 | 294/18723 | 3.80e-08 | 8.30e-07 | 171 |
GO:00192162 | Liver | HCC | regulation of lipid metabolic process | 181/7958 | 331/18723 | 4.58e-06 | 5.79e-05 | 181 |
GO:00301932 | Liver | HCC | regulation of blood coagulation | 46/7958 | 66/18723 | 7.12e-06 | 8.47e-05 | 46 |
GO:00517022 | Liver | HCC | biological process involved in interaction with symbiont | 60/7958 | 94/18723 | 2.41e-05 | 2.54e-04 | 60 |
GO:19000462 | Liver | HCC | regulation of hemostasis | 46/7958 | 68/18723 | 2.43e-05 | 2.56e-04 | 46 |
GO:00508182 | Liver | HCC | regulation of coagulation | 47/7958 | 71/18723 | 4.68e-05 | 4.50e-04 | 47 |
GO:001081022 | Liver | HCC | regulation of cell-substrate adhesion | 123/7958 | 221/18723 | 5.15e-05 | 4.90e-04 | 123 |
GO:004206022 | Liver | HCC | wound healing | 219/7958 | 422/18723 | 5.34e-05 | 5.04e-04 | 219 |
GO:006104122 | Liver | HCC | regulation of wound healing | 78/7958 | 134/18723 | 1.73e-04 | 1.36e-03 | 78 |
GO:003158922 | Liver | HCC | cell-substrate adhesion | 188/7958 | 363/18723 | 2.00e-04 | 1.55e-03 | 188 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PLG | SNV | Missense_Mutation | novel | c.871N>T | p.Val291Leu | p.V291L | P00747 | protein_coding | tolerated(0.3) | benign(0.003) | TCGA-3C-AAAU-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | zoladex | SD |
PLG | SNV | Missense_Mutation | novel | c.1833N>C | p.Leu611Phe | p.L611F | P00747 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-5L-AAT1-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Hormone Therapy | letrozol | SD |
PLG | SNV | Missense_Mutation | novel | c.22C>A | p.Leu8Ile | p.L8I | P00747 | protein_coding | tolerated(0.05) | benign(0.368) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PLG | SNV | Missense_Mutation | | c.1993N>C | p.Asp665His | p.D665H | P00747 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AN-A0XW-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
PLG | SNV | Missense_Mutation | novel | c.1670N>C | p.Val557Ala | p.V557A | P00747 | protein_coding | deleterious(0) | benign(0.411) | TCGA-AR-A2LJ-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD |
PLG | SNV | Missense_Mutation | novel | c.866T>G | p.Val289Gly | p.V289G | P00747 | protein_coding | deleterious(0) | possibly_damaging(0.897) | TCGA-B6-A0I5-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PLG | SNV | Missense_Mutation | | c.747N>A | p.Asp249Glu | p.D249E | P00747 | protein_coding | tolerated(0.05) | benign(0.167) | TCGA-BH-A0BP-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PLG | SNV | Missense_Mutation | novel | c.866T>G | p.Val289Gly | p.V289G | P00747 | protein_coding | deleterious(0) | possibly_damaging(0.897) | TCGA-BH-A0HO-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | SD |
PLG | SNV | Missense_Mutation | | c.1078G>A | p.Glu360Lys | p.E360K | P00747 | protein_coding | tolerated(0.1) | benign(0.345) | TCGA-D8-A1JA-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | PD |
PLG | SNV | Missense_Mutation | novel | c.288N>T | p.Lys96Asn | p.K96N | P00747 | protein_coding | deleterious(0) | possibly_damaging(0.906) | TCGA-E2-A2P5-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | arimidex | PD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5340 | PLG | DRUGGABLE GENOME, ENZYME, CELL SURFACE, PROTEASE | | UROKINASE | UROKINASE | |
5340 | PLG | DRUGGABLE GENOME, ENZYME, CELL SURFACE, PROTEASE | | ALTEPLASE | ALTEPLASE | |
5340 | PLG | DRUGGABLE GENOME, ENZYME, CELL SURFACE, PROTEASE | | ALTEPLASE | ALTEPLASE | |
5340 | PLG | DRUGGABLE GENOME, ENZYME, CELL SURFACE, PROTEASE | | DESMOTEPLASE | DESMOTEPLASE | |
5340 | PLG | DRUGGABLE GENOME, ENZYME, CELL SURFACE, PROTEASE | | Reteplase | RETEPLASE | |
5340 | PLG | DRUGGABLE GENOME, ENZYME, CELL SURFACE, PROTEASE | | NYSTATIN | NYSTATIN | 7721938 |
5340 | PLG | DRUGGABLE GENOME, ENZYME, CELL SURFACE, PROTEASE | | ANISTREPLASE | ANISTREPLASE | |
5340 | PLG | DRUGGABLE GENOME, ENZYME, CELL SURFACE, PROTEASE | | RETEPLASE | RETEPLASE | |
5340 | PLG | DRUGGABLE GENOME, ENZYME, CELL SURFACE, PROTEASE | | BORTEZOMIB | BORTEZOMIB | 20875739 |
5340 | PLG | DRUGGABLE GENOME, ENZYME, CELL SURFACE, PROTEASE | | ANTIDEPRESSANTS | | 16890384 |